Alkermes, Biogen Exempt New States from 340B Contract Pharmacy Restrictions

Alkermes has added Hawaii, South Dakota and Vermont to the list of states exempted from its 340B contract pharmacy restrictions.
Two major drugmakers recently announced additional states that will no longer be subject to their 340B contract pharmacy restrictions following [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drug Industry Takes Aim at 340B Program’s Growth in Pair of Op-Eds

PhRMA President and CEO Steve Ubl and Joe Grogan, a former Trump assistant and director of the White House’s Domestic Policy Council, took aim at the 340B program in a pair of recent op-eds.
The head of an influential drug industry trade group and a former Trump administration official recently called for federal 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

Federal Judge Dismisses J&J’s Lawsuit, Rules HHS Must Preapprove 340B Rebate Models

A federal district judge in Washington. D.C. on Friday rejected J&J's lawsuit challenging HHS' authority to preapprove 340B rebate models.
A federal district judge today upheld the Department of Health and Human Services’ (HHS) authority to preapprove 340B rebate models, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers Urge Appeals Court to Toss Hospital Group’s Cross-Appeal in 340B Rebate Case

Three drugmakers recently asked a federal appeals court in Washington, D.C. to dismiss 340B Health's cross-appeal filed as part of ongoing 340B rebate litigation.
In their second emergency motion this month, a group of drugmakers is urging a federal appeals court to reject a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

RFK Jr. Touts HHS Budget Plan, PBM Reform & Drug Pricing Efforts; Rep. Harshbarger Suggests 340B Contract Changes

HHS Secretary Robert F. Kennedy Jr. testified before the U.S. House E&C Committee’s Health Subcommittee Tuesday on the president’s HHS budget.
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. this week defended President Donald Trump’s Fiscal Year 2026 proposed [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Four Drugmakers Announce New State Exemptions from 340B Contract Pharmacy Restrictions

Amgen is one of four drugmakers to have recently exempted new states from its 340B contract pharmacy restrictions.
Drugmakers Amgen, GSK, Merck and Sobi recently announced they are exempting more states from their 340B contract pharmacy restrictions amid [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Maine Enacts 340B Contract Pharmacy Access Law with Added Hospital Reporting Requirements

Maine Gov. Janet Mills (D) on June 20 signed a budget bill with 340B contract pharmacy protections and expanded hospital reporting requirements.
Maine recently became the 20th state to enact a 340B contract pharmacy access law as part of a sweeping budget [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Drugmakers, Hospital Group Appeal Dueling Aspects of 340B Rebate Ruling

Multiple drugmakers and an intervening hospital trade group are appealing different aspects of a federal district judge's ruling on 340B rebates.
Three drugmakers and a drug industry tech firm are urging a federal appeals court to overturn a ruling that blocked [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Q+A: Kalderos CEO Angie Franks Talks Truzo, 340B Program Transparency

Kalderos CEO Angie Franks recently spoke with 340B Report about the current battle over 340B rebate models, among other things.
Health technology company Kalderos has made waves in the 340B world in recent years after emerging as a key player [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Trump’s ‘Most Favored Nation’ Order Could Lower 340B Ceiling Prices, but Key Details Remain Unclear

President Donald Trump's "most favored nation" executive order has unclear effects on the 340B program.
President Donald Trump’s recent executive order directing federal agencies to pursue “most favored nation” (MFN) pricing for prescription drugs could [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live